NVIDIA announced a platform for the medical device industry to develop and deploy real-time AI applications, specifically designed to meet required regulatory standards.

The Clara Holoscan MGX expands the Clara Holoscan platform to provide an all-in-one, medical-grade reference architecture, as well as long-term software support, to accelerate innovation in the medical device industry.

 It brings a new level of sensor innovation to edge computing by processing high-throughput data streams for real-time insights.

“Deploying real-time AI in healthcare and life sciences is critical to enable the next frontiers in surgery, diagnostics and drug discovery,” says Kimberly Powell, vice president of healthcare at NVIDIA. “Clara Holoscan MGX, with its unique combination of AI, accelerated computing and advanced visualization, accelerates the productization of AI and provides software-as-a-service business models for the medical device industry.”

As part of Clara Holoscan MGX, NVIDIA provides hardware reference design with long-life NVIDIA components and 10-year long-term software support, including IEC62304 documentation for software and IEC60601 attestation reports from embedded computing partners.

ADLINKAdvantechDedicated ComputingKontronLeadtekMBX SystemsOnyx HealthcarePortwellProdrive TechnologiesRYOYO Electro and Yuan High-Tech will be the first embedded-computing manufacturers to build products based on the Clara Holoscan MGX reference design to serve the needs of the global medical device industry.

Several major medical devices makers and a number of robotic surgery and medical imaging startups are already developing on the Clara Holoscan platform.

Featured image: NVIDIA Clara Holoscan MGX is a platform for the medical-device industry to develop and deploy real-time AI applications at the edge, specifically designed to meet required regulatory standards. Photo: NVIDIA